| http://www.w3.org/ns/prov#value | - by NSCLC via secretion of IL-17.We recently reported that IL-17 is an angiogenic factor, whichstimulates the migration and cord formation of vascular endothe-lial cells in vitro and elicits neovessel formation in vivo (37, 58).Thus, it is a little strange that the enhanced NSCLC growth me-diated by IL-17 was largely impaired in mice treated with anti-CXCR-2 Ab.
|
